Journal
CURRENT DRUG TARGETS
Volume 12, Issue 10, Pages 1417-1423Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138945011796818216
Keywords
Ulcerative colitis; inflammatory bowel disease; mucosal healing; colonoscopy; medical therapy
Categories
Ask authors/readers for more resources
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation affecting the colonic mucosa, that can extend to the whole large bowel. The severity of mucosal lesions directly reflects the disease activity and severity and may be prognostic for an aggressive behavior of the pathology. Remission, is usually defined as resolution of symptoms. Recently, mucosal healing (MH) has emerged as an important end point of any short-term medical therapy for IBD. It may predict long-term remission and may impact on the natural history of the disease in Crohn's disease (CD), while data in UC patients are still limited. This review of the literature is focused on the recent evidence on the impact of medications on MH in UC and on the impact of MH on the natural course of UC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available